PTEN, Akt, MAPK, p53 and p95 expression to predict trastuzumab resistance in HER2 positive breast cancer.
Year: 2013
Type: article
Study design: Observational Study
Source: PubMed
Authors: B B Duman, B Sahin, A Acikalin, M Ergin, S Zorludemir
Institution: Cukurova University
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W185747279
